Tetraphase Pharmaceuticals, Inc. (TTPH) Financial Statements (2024 and earlier)

Company Profile

Business Address 480 ARSENAL WAY
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 21,239107,776136,411142,086205,912121,042
Cash and cash equivalents 21,239107,776136,411142,086205,912121,042
Receivables 1,5032,2744,6531,7894,1513,458
Inventory, net of allowances, customer advances and progress billings 1,595748    
Inventory 1,595748    
Contract with customer, asset, after allowance for credit loss  3,000
Asset, held-for-sale, not part of disposal group 53    
Other undisclosed current assets 2,1032,6746,3826,5823,7052,097
Total current assets: 26,493116,472147,446150,457213,768126,597
Noncurrent Assets
Operating lease, right-of-use asset 4,836
Property, plant and equipment 981,1211,3951,054943300
Intangible assets, net (including goodwill), including: 4,2594,652    
Other undisclosed intangible assets, net (including goodwill) 4,2594,652    
Restricted cash and investments 699699199199199199
Other noncurrent assets     7108
Total noncurrent assets: 9,8926,4721,5941,2531,149607
TOTAL ASSETS: 36,385122,944149,040151,710214,917127,204
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 8,22314,95717,86510,2409,78815,940
Employee-related liabilities      2,358
Accounts payable 2,4293,2105,3062,5552,8574,105
Accrued liabilities 5,79411,74712,5597,6856,9319,477
Debt 1,547    3,436
Deferred revenue and credits6601,255909258
Contract with customer, liability6
Other undisclosed current liabilities      (2,358)
Total current liabilities: 9,77014,96318,52511,49510,69717,276
Noncurrent Liabilities
Long-term debt and lease obligation 3,44828,291   1,124
Long-term debt, excluding current maturities  28,291   1,124
Liabilities, other than long-term debt  810516216516
Deferred revenue and credits  16516
Other liabilities  8105162  
Operating lease, liability 3,448
Total noncurrent liabilities: 3,44828,2991051621651,140
Total liabilities: 13,21843,26218,63011,65710,86218,416
Equity
Equity, attributable to parent 23,16779,682130,410140,053204,055108,566
Common stock 35351373731
Additional paid in capital 627,291613,671592,243487,148473,670294,998
Accumulated deficit (604,127)(534,042)(461,884)(347,132)(269,652)(186,463)
Total equity: 23,16779,682130,410140,053204,055108,566
Other undisclosed liabilities and equity      222
TOTAL LIABILITIES AND EQUITY: 36,385122,944149,040151,710214,917127,204

Income Statement (P&L) ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 7,37618,9049,6665,14511,6869,098
Gross profit: 7,37618,9049,6665,14511,6869,098
Operating expenses (74,908)(92,185)(125,381)(82,975)(94,684)(87,798)
Other undisclosed operating income      12,934
Operating loss: (67,532)(73,281)(115,715)(77,830)(82,998)(65,766)
Nonoperating income (expense) 1,5951,747963350(191)(976)
Investment income, nonoperating 1,2621,747 3504217
Other nonoperating income (expense) 333 963 (2)24
Interest and debt expense (4,148)(624)  (231)(1,017)
Other undisclosed income from continuing operations before equity method investments, income taxes     83,337 
Loss from continuing operations: (70,085)(72,158)(114,752)(77,480)(83)(67,759)
Loss before gain (loss) on sale of properties: (70,185)(72,158)(114,752)(77,480)(83)(67,759)
Loss from discontinued operations (100)     
Net loss: (70,185)(72,158)(114,752)(77,480)(83)(67,759)
Other undisclosed net income (loss) attributable to parent 100   (83,106)1,017
Net loss available to common stockholders, diluted: (70,085)(72,158)(114,752)(77,480)(83,189)(66,742)

Comprehensive Income ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (70,185)(72,158)(114,752)(77,480)(83)(67,759)
Comprehensive loss: (70,185)(72,158)(114,752)(77,480)(83)(67,759)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 100   (83,106)1,017
Comprehensive loss, net of tax, attributable to parent: (70,085)(72,158)(114,752)(77,480)(83,189)(66,742)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: